180 related articles for article (PubMed ID: 26774260)
1. Autoantibody signatures defined by serological proteome analysis in sera from patients with cholangiocarcinoma.
Mustafa MZ; Nguyen VH; Le Naour F; De Martin E; Beleoken E; Guettier C; Johanet C; Samuel D; Duclos-Vallee JC; Ballot E
J Transl Med; 2016 Jan; 14():17. PubMed ID: 26774260
[TBL] [Abstract][Full Text] [Related]
2. Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma.
Rucksaken R; Pairojkul C; Pinlaor P; Khuntikeo N; Roytrakul S; Selmi C; Pinlaor S
PLoS One; 2014; 9(7):e103259. PubMed ID: 25058392
[TBL] [Abstract][Full Text] [Related]
3. Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis.
Tamesa MS; Kuramitsu Y; Fujimoto M; Maeda N; Nagashima Y; Tanaka T; Yamamoto S; Oka M; Nakamura K
Electrophoresis; 2009 Jun; 30(12):2168-81. PubMed ID: 19582718
[TBL] [Abstract][Full Text] [Related]
4. A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma.
Boonjaraspinyo S; Juasook A; Boonmars T; Aukkanimart R; Silsirivanit A; Loilome W; Sriraj P; Wu Z; Ratanasuwan P
Asian Pac J Cancer Prev; 2015; 16(14):5779-85. PubMed ID: 26320451
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients.
Cavalloni G; Peraldo-Neia C; Massa A; Bergamini C; Trentini A; De Rosa G; Daniele L; Ciccosanti F; Cervellati C; Leone F; Aglietta M
BMC Cancer; 2021 Jul; 21(1):865. PubMed ID: 34320944
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma.
Takashima M; Kuramitsu Y; Yokoyama Y; Iizuka N; Harada T; Fujimoto M; Sakaida I; Okita K; Oka M; Nakamura K
Proteomics; 2006 Jul; 6(13):3894-900. PubMed ID: 16767786
[TBL] [Abstract][Full Text] [Related]
7. Identification of new autoantibody specificities directed at proteins involved in the transforming growth factor β pathway in patients with systemic sclerosis.
Bussone G; Dib H; Tamby MC; Broussard C; Federici C; Woimant G; Camoin L; Guillevin L; Mouthon L
Arthritis Res Ther; 2011 May; 13(3):R74. PubMed ID: 21569507
[TBL] [Abstract][Full Text] [Related]
8. Circulating markers of biliary malignancy: opportunities in proteomics?
Bonney GK; Craven RA; Prasad R; Melcher AF; Selby PJ; Banks RE
Lancet Oncol; 2008 Feb; 9(2):149-58. PubMed ID: 18237849
[TBL] [Abstract][Full Text] [Related]
9. [Proteome analysis of autoantibodies in sera of patients with cancer].
Ueda K
Rinsho Byori; 2005 May; 53(5):437-45. PubMed ID: 15966408
[TBL] [Abstract][Full Text] [Related]
10. [Screening hepatocellular carcinoma autoantibodies by serological proteome analysis].
Feng JT; Liu YK; Dai Z; Zhou HJ; Song HY; Qin LX; Jin H; Lu HJ; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2005 Nov; 13(11):832-5. PubMed ID: 16313728
[TBL] [Abstract][Full Text] [Related]
11. Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.
Sanchez TW; Zhang G; Li J; Dai L; Mirshahidi S; Wall NR; Yates C; Wilson C; Montgomery S; Zhang JY; Casiano CA
Mol Cell Proteomics; 2016 Dec; 15(12):3564-3580. PubMed ID: 27742740
[TBL] [Abstract][Full Text] [Related]
12. [Proteomic analysis of serum and serum exosomes, and their application in intrahepatic cholangiocarcinoma].
Yang K; Wang W; Wang Y; Yan C
Se Pu; 2021 Nov; 39(11):1191-1202. PubMed ID: 34677014
[TBL] [Abstract][Full Text] [Related]
13. Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
Jendrek ST; Gotthardt D; Nitzsche T; Widmann L; Korf T; Michaels MA; Weiss KH; Liaskou E; Vesterhus M; Karlsen TH; Mindorf S; Schemmer P; Bär F; Teegen B; Schröder T; Ehlers M; Hammers CM; Komorowski L; Lehnert H; Fellermann K; Derer S; Hov JR; Sina C
Gut; 2017 Jan; 66(1):137-144. PubMed ID: 27406039
[TBL] [Abstract][Full Text] [Related]
14. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma.
Julich-Haertel H; Urban SK; Krawczyk M; Willms A; Jankowski K; Patkowski W; Kruk B; Krasnodębski M; Ligocka J; Schwab R; Richardsen I; Schaaf S; Klein A; Gehlert S; Sänger H; Casper M; Banales JM; Schuppan D; Milkiewicz P; Lammert F; Krawczyk M; Lukacs-Kornek V; Kornek M
J Hepatol; 2017 Aug; 67(2):282-292. PubMed ID: 28267620
[TBL] [Abstract][Full Text] [Related]
16. New antigenic candidates in multiple sclerosis: identification by serological proteome analysis.
Almeras L; Lefranc D; Drobecq H; de Seze J; Dubucquoi S; Vermersch P; Prin L
Proteomics; 2004 Jul; 4(7):2184-94. PubMed ID: 15221778
[TBL] [Abstract][Full Text] [Related]
17. Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.
Srisomsap C; Sawangareetrakul P; Subhasitanont P; Chokchaichamnankit D; Chiablaem K; Bhudhisawasdi V; Wongkham S; Svasti J
J Biomed Biotechnol; 2010; 2010():437143. PubMed ID: 20069059
[TBL] [Abstract][Full Text] [Related]
18. A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma.
Shi Y; Deng X; Zhan Q; Shen B; Jin X; Zhu Z; Chen H; Li H; Peng C
J Gastrointest Surg; 2013 Sep; 17(9):1584-91. PubMed ID: 23868055
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of cholangiocarcinoma cell line.
Srisomsap C; Sawangareetrakul P; Subhasitanont P; Panichakul T; Keeratichamroen S; Lirdprapamongkol K; Chokchaichamnankit D; Sirisinha S; Svasti J
Proteomics; 2004 Apr; 4(4):1135-44. PubMed ID: 15048994
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers.
Ummanni R; Duscharla D; Barett C; Venz S; Schlomm T; Heinzer H; Walther R; Bokemeyer C; Brümmendorf TH; Murthy PV; Balabanov S
J Proteomics; 2015 Apr; 119():218-29. PubMed ID: 25724726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
